Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2019-09-09

Clinical Trial Update: Evaluation of Effect of Alirocumab on Coronary Atheroma Volume in Japanese Patients Hospitalized for Acute Coronary Syndrome With Hypercholesterolemia [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the effect of alirocumab on coronary atheroma volume in Japanese patients hospitalized for acute coronary syndrome with hypercholeste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • alirocumab (alirocumab)

Snippet

Sponsor: Sanofi | Conditions: Hypercholesterolemia, Acute Coronary Syndrome | Phase 4 | Status: COMPLETED | Results posted: 2019-09-09